5-Hydroxytryptamine 7 receptor (5-HT7R)

The 5-Hydroxytryptamine 7 receptor (5-HT7R) is the most recently identified member of the serotonin receptor family and belongs to the G protein-coupled receptor (GPCR) superfamily. It is widely expressed in the central nervous system, particularly in the thalamus, hypothalamus, hippocampus, and cortex, as well as in peripheral tissues like the gastrointestinal tract and blood vessels. Biologically, the 5-HT7 receptor plays a critical role in regulating circadian rhythms, thermoregulation, and cognitive processes such as learning and memory. In disease states, it has been strongly implicated in the pathophysiology of depression, anxiety, and schizophrenia, making it a significant target for atypical antipsychotics and next-generation antidepressants. Many clinically used drugs, such as lurasidone and vortioxetine, derive part of their therapeutic efficacy from high-affinity antagonism of this receptor. Beyond psychiatry, the 5-HT7 receptor is being investigated for its roles in chronic pain management and inflammatory bowel conditions due to its influence on smooth muscle tone and neuroinflammation.

Other names

HTR7Serotonin receptor 75-HT7

The 5-HT7 receptor primarily couples to Gs proteins, leading to the activation of adenylyl cyclase and an increase in intracellular cyclic AMP (cAMP) levels. It can also interact with G12 proteins to modulate the actin cytoskeleton and neuronal morphology. Therapeutic agents typically act as antagonists to treat mood disorders or as agonists to explore cognitive enhancement and pain management.